Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Teduglutide

Teduglutide

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Teduglutide

16 trials tracked of Teduglutide: 13 in phase 3 or 4 and 2 with published results. The most-cited published study has 3 citations.

16Trials tracked
13Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 12 Phase 2 2 Phase 1 1
  1. Phase 3 A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302 Completed · 3 cited
  2. Phase 3 A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older Completed
  3. Phase 4 Short Bowel Syndrome and Teduglutide Versus Placebo Completed
  4. Phase 3 An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 Completed
  5. Phase 3 Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects Completed
  6. Phase 3 Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support Completed
Show 10 more trials
  1. Phase 3 Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Completed
  2. Phase 3 Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS) Completed
  3. Phase 3 Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study Completed
  4. Phase 3 Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Completed
  5. Phase 3 A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 Completed
  6. Phase 3 A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Completed
  7. Phase 3 Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) Completed
  8. Phase 2 Teduglutide for Enterocutaneous Fistula (ECF) Completed
  9. Phase 2 A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV Completed
  10. Phase 1 A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants Completed

Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.